89bio Inc (ETNB)

Taking a Closer Look At 89bio Inc (ETNB) Following Its Recent Trade – Knox Daily - Knox Daily

Knox Daily

Where are the Opportunities in (ETNB) - Stock Traders Daily

Stock Traders Daily

HC Wainwright Reiterates Buy Rating for 89bio (NASDAQ:ETNB) - Defense World

Defense World

Eyenovia (NASDAQ:EYEN) vs. 89bio (NASDAQ:ETNB) Head-To-Head Contrast - Defense World

Defense World

89bio (NASDAQ:ETNB) Stock Rating Reaffirmed by Cantor Fitzgerald - Defense World

Defense World

89bio (NASDAQ:ETNB) Stock Rating Reaffirmed by Cantor Fitzgerald - MarketBeat

MarketBeat

89bio (NASDAQ:ETNB) PT Lowered to $33.00 at Evercore ISI - Defense World

Defense World

New York State Common Retirement Fund Boosts Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World

Defense World

Insider Selling: PALEKAR ROHAN, 89bio Inc [ETNB] Chief Executive Officer divested 52718 shares – Knox Daily - Knox Daily

Knox Daily

89bio (NASDAQ:ETNB) Receives Buy Rating from HC Wainwright - MarketBeat

MarketBeat

Cantor Fitzgerald Comments on 89bio, Inc.'s FY2024 Earnings (NASDAQ:ETNB) - Defense World

Defense World

89bio (NASDAQ:ETNB) Trading Up 5.5% - MarketBeat

MarketBeat

89bio, Inc. (NASDAQ:ETNB) to Post FY2024 Earnings of ($2.30) Per Share, Cantor Fitzgerald Forecasts - MarketBeat

MarketBeat

89bio (NASDAQ:ETNB) Price Target Cut to $33.00 by Analysts at Evercore ISI - MarketBeat

MarketBeat

Is it possible to buy 89bio Inc(ETNB) shares at a good price now? – US Post News - US Post News

US Post News

89bio shares target cut to $33 on higher expenses - Investing.com

Investing.com

89bio, Inc. (NASDAQ:ETNB) insider upped their holding by 23% earlier this year - Yahoo New Zealand News

Yahoo New Zealand News

Gaining Ground: 89bio Inc (ETNB) Closes Lower at 8.70, Down -0.11 – DWinneX - The Dwinnex

The Dwinnex

A new trading data show 89bio Inc (ETNB) is showing positive returns. – Sete News - SETE News

SETE News

89bio (NASDAQ:ETNB) Price Target Cut to $29.00 - Defense World

Defense World

BofA Securities's latest rating for ETNB stock – Knox Daily - Knox Daily

Knox Daily

89bio shares target cut, maintains buy rating By Investing.com - Investing.com

Investing.com

89bio (NASDAQ:ETNB) Price Target Lowered to $29.00 at HC Wainwright - MarketBeat

MarketBeat

89bio (NASDAQ:ETNB) Issues Earnings Results - MarketBeat

MarketBeat

(ETNB) Trading Signals - Stock Traders Daily

Stock Traders Daily

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - WICZ

WICZ

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

RBC Capital cuts 89bio shares target on model adjustments - Investing.com India

Investing.com India

RBC Capital cuts 89bio shares target on model adjustments - Investing.com

Investing.com

RBC Capital cuts 89bio shares target on model adjustments - Investing.com UK

Investing.com UK

89bio (NASDAQ:ETNB) Price Target Lowered to $29.00 at HC Wainwright - MarketBeat

MarketBeat

Zurcher Kantonalbank Zurich Cantonalbank Purchases 7692 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World

Defense World

Views of Wall Street's Leading Experts on 89bio Inc – Sete News - SETE News

SETE News

New Strong Sell Stocks for January 21st - Yahoo Movies UK

Yahoo Movies UK

Latest Insider moments: PALEKAR ROHAN, 89bio Inc [ETNB] Chief Executive Officer sold 52718 shares – Knox Daily - Knox Daily

Knox Daily

All You Need to Know About 89BIO (ETNB) Rating Upgrade to Buy - Zacks Investment Research

Zacks Investment Research

All You Need to Know About 89BIO (ETNB) Rating Upgrade to Buy - Yahoo Finance UK

Yahoo Finance UK

89bio, Inc. (NASDAQ:ETNB) insider upped their holding by 23% earlier this year - Yahoo New Zealand News

Yahoo New Zealand News

89bio to Host Key Opinion Leader Webinar on Pegozafermin’s Opportunity in Advanced MASH - ForexTV.com

ForexTV.com

(ETNB) On The My Stocks Page - Stock Traders Daily

Stock Traders Daily

An Analysis of 89bio Inc (ETNB)'s Potential Price Growth – Knox Daily - Knox Daily

Knox Daily

89bio, Inc. (NASDAQ:ETNB) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Defense World

89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors

GlobeNewswire Inc.

89bio adds biotech veteran Martin Babler to board - Investing.com

Investing.com

PRIME Scheme: EMA Says Yes To Hookipa, Bluejay & 89bio But No To Six Others - Pink Sheet

Pink Sheet

89bio signs deal for construction of a production facility in China (NASDAQ:ETNB) - Seeking Alpha

Seeking Alpha

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

89bio CEO Rohan Palekar trades over $620k in company stock - Investing.com

Investing.com

89bio Receives EMA PRIME Status for Pegozafermin in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Fibrosis and Compensated Cirrhosis

GlobeNewswire Inc.

89bio wins EMA priority status for MASH candidate pegozafermin - Pharmaceutical Technology

Pharmaceutical Technology